EDGAR Filing Documents for 0001214659-14-001324

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001214659-14-001324

Filing Date

2014-02-20

Accepted

2014-02-20 13:43:01

Documents

Group Members

BIOVISION LIFE SCIENCE FUND NO.1SBI BB MEDIA INVESTMENT LIMITED PARTNERSHIPSBI BB MOBILE INVESTMENT LPSSBI BIO LIFE SCIENCE INVESTMENT LPSSBI BROADBAND FUND NO. 1 LIMITED PARTNERSHIPSBI CAPITAL MANAGEMENT CO. LTD.SBI INCUBATION CO. LTD.SBI INVESTMENT CO.

Document Format Files

Seq	Description	Document	Type	Size
1		j218140sc13d.htm	SC 13D	541364
	Complete submission text file	0001214659-14-001324.txt		543684

Mailing Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101

Business Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101 206-805-8300

ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88011 | Film No.: 14628695
SIC: 2834 Pharmaceutical Preparations

Mailing Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019

Business Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019 81-3-6229-0122

SBI Holdings, Inc. (Filed by) CIK: 0001446698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D